+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

CGRP-Directed Migraine Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, and Product Type

  • PDF Icon

    Report

  • 90 Pages
  • January 2024
  • Region: Global
  • Prof Research
  • ID: 5727933
Description Jump to:
This report describes the global market size of CGRP-Directed Migraine Treatment from 2019 to 2023 and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029.

For the geography segment; regional supply, demand, major players, and price is presented from 2019 to 2029. This report covers the following regions:

  • North America
  • South America
  • Asia & Pacific
  • Europe
  • MEA
The key countries for each region are also included, such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For the competitor segment, the report includes global key players of CGRP-Directed Migraine Treatment as well as some small players.

The information for each competitor includes:

  • Company Profile
  • Business Information
  • SWOT Analysis
  • Revenue, Gross Margin and Market Share

Types Segment:

  • galcanezumab
  • erenumabb
  • fremanezumab
  • eptinezumab
  • Ubrogepant
  • rimegepant
  • Others

Companies Covered:

  • Eli Lilly
  • Amgen/Novartis
  • Teva
  • Lundbeck
  • Allergan
  • Biohaven
Base Year: 2024
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2029

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter Four Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 COVID-19 Impact
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Cgrp-Directed Migraine Treatment Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Cgrp-Directed Migraine Treatment Market in North America (2019-2029)
8.1 Cgrp-Directed Migraine Treatment Market Size
8.2 Cgrp-Directed Migraine Treatment Market by End Use
8.3 Competition by Players/Suppliers
8.4 Cgrp-Directed Migraine Treatment Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Cgrp-Directed Migraine Treatment Market in South America (2019-2029)
9.1 Cgrp-Directed Migraine Treatment Market Size
9.2 Cgrp-Directed Migraine Treatment Market by End Use
9.3 Competition by Players/Suppliers
9.4 Cgrp-Directed Migraine Treatment Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Cgrp-Directed Migraine Treatment Market in Asia & Pacific (2019-2029)
10.1 Cgrp-Directed Migraine Treatment Market Size
10.2 Cgrp-Directed Migraine Treatment Market by End Use
10.3 Competition by Players/Suppliers
10.4 Cgrp-Directed Migraine Treatment Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Cgrp-Directed Migraine Treatment Market in Europe (2019-2029)
11.1 Cgrp-Directed Migraine Treatment Market Size
11.2 Cgrp-Directed Migraine Treatment Market by End Use
11.3 Competition by Players/Suppliers
11.4 Cgrp-Directed Migraine Treatment Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Cgrp-Directed Migraine Treatment Market in MEA (2019-2029)
12.1 Cgrp-Directed Migraine Treatment Market Size
12.2 Cgrp-Directed Migraine Treatment Market by End Use
12.3 Competition by Players/Suppliers
12.4 Cgrp-Directed Migraine Treatment Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Cgrp-Directed Migraine Treatment Market (2019-2024)
13.1 Cgrp-Directed Migraine Treatment Market Size
13.2 Cgrp-Directed Migraine Treatment Market by End Use
13.3 Competition by Players/Suppliers
13.4 Cgrp-Directed Migraine Treatment Market Size by Type
Chapter 14 Global Cgrp-Directed Migraine Treatment Market Forecast (2024-2029)
14.1 Cgrp-Directed Migraine Treatment Market Size Forecast
14.2 Cgrp-Directed Migraine Treatment Application Forecast
14.3 Competition by Players/Suppliers
14.4 Cgrp-Directed Migraine Treatment Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Eli Lilly
15.1.1 Company Profile
15.1.2 Main Business and CGRP-Directed Migraine Treatment Information
15.1.3 SWOT Analysis of Eli Lilly
15.1.4 Eli Lilly CGRP-Directed Migraine Treatment Revenue, Gross Margin and Market Share (2019-2024)
15.2 Amgen/Novartis
15.2.1 Company Profile
15.2.2 Main Business and CGRP-Directed Migraine Treatment Information
15.2.3 SWOT Analysis of Amgen/Novartis
15.2.4 Amgen/Novartis CGRP-Directed Migraine Treatment Revenue, Gross Margin and Market Share (2019-2024)
15.3 Teva
15.3.1 Company Profile
15.3.2 Main Business and CGRP-Directed Migraine Treatment Information
15.3.3 SWOT Analysis of Teva
15.3.4 Teva CGRP-Directed Migraine Treatment Revenue, Gross Margin and Market Share (2019-2024)
15.4 Lundbeck
15.4.1 Company Profile
15.4.2 Main Business and CGRP-Directed Migraine Treatment Information
15.4.3 SWOT Analysis of Lundbeck
15.4.4 Lundbeck CGRP-Directed Migraine Treatment Revenue, Gross Margin and Market Share (2019-2024)
15.5 Allergan
15.5.1 Company Profile
15.5.2 Main Business and CGRP-Directed Migraine Treatment Information
15.5.3 SWOT Analysis of Allergan
15.5.4 Allergan CGRP-Directed Migraine Treatment Revenue, Gross Margin and Market Share (2019-2024)
15.6 Biohaven
15.6.1 Company Profile
15.6.2 Main Business and CGRP-Directed Migraine Treatment Information
15.6.3 SWOT Analysis of Biohaven
15.6.4 Biohaven CGRP-Directed Migraine Treatment Revenue, Gross Margin and Market Share (2019-2024)
List of Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Cgrp-Directed Migraine Treatment Report
Table Data Sources of Cgrp-Directed Migraine Treatment Report
Table Major Assumptions of Cgrp-Directed Migraine Treatment Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Cgrp-Directed Migraine Treatment Picture
Table Cgrp-Directed Migraine Treatment Classification
Table Cgrp-Directed Migraine Treatment Applications
Table Drivers of Cgrp-Directed Migraine Treatment Market
Table Restraints of Cgrp-Directed Migraine Treatment Market
Table Opportunities of Cgrp-Directed Migraine Treatment Market
Table Threats of Cgrp-Directed Migraine Treatment Market
Table COVID-19 Impact For Cgrp-Directed Migraine Treatment Market
Table Raw Materials Suppliers
Table Different Production Methods of Cgrp-Directed Migraine Treatment
Table Cost Structure Analysis of Cgrp-Directed Migraine Treatment
Table Key End Users
Table Latest News of Cgrp-Directed Migraine Treatment Market
Table Merger and Acquisition
Table Planned/Future Project of Cgrp-Directed Migraine Treatment Market
Table Policy of Cgrp-Directed Migraine Treatment Market
Table 2019-2029 North America Cgrp-Directed Migraine Treatment Market Size
Figure 2019-2029 North America Cgrp-Directed Migraine Treatment Market Size and CAGR
Table 2019-2029 North America Cgrp-Directed Migraine Treatment Market Size by Application
Table 2019-2024 North America Cgrp-Directed Migraine Treatment Key Players Revenue
Table 2019-2024 North America Cgrp-Directed Migraine Treatment Key Players Market Share
Table 2019-2029 North America Cgrp-Directed Migraine Treatment Market Size by Type
Table 2019-2029 United States Cgrp-Directed Migraine Treatment Market Size
Table 2019-2029 Canada Cgrp-Directed Migraine Treatment Market Size
Table 2019-2029 Mexico Cgrp-Directed Migraine Treatment Market Size
Table 2019-2029 South America Cgrp-Directed Migraine Treatment Market Size
Figure 2019-2029 South America Cgrp-Directed Migraine Treatment Market Size and CAGR
Table 2019-2029 South America Cgrp-Directed Migraine Treatment Market Size by Application
Table 2019-2024 South America Cgrp-Directed Migraine Treatment Key Players Revenue
Table 2019-2024 South America Cgrp-Directed Migraine Treatment Key Players Market Share
Table 2019-2029 South America Cgrp-Directed Migraine Treatment Market Size by Type
Table 2019-2029 Brazil Cgrp-Directed Migraine Treatment Market Size
Table 2019-2029 Argentina Cgrp-Directed Migraine Treatment Market Size
Table 2019-2029 Chile Cgrp-Directed Migraine Treatment Market Size
Table 2019-2029 Peru Cgrp-Directed Migraine Treatment Market Size
Table 2019-2029 Asia & Pacific Cgrp-Directed Migraine Treatment Market Size
Figure 2019-2029 Asia & Pacific Cgrp-Directed Migraine Treatment Market Size and CAGR
Table 2019-2029 Asia & Pacific Cgrp-Directed Migraine Treatment Market Size by Application
Table 2019-2024 Asia & Pacific Cgrp-Directed Migraine Treatment Key Players Revenue
Table 2019-2024 Asia & Pacific Cgrp-Directed Migraine Treatment Key Players Market Share
Table 2019-2029 Asia & Pacific Cgrp-Directed Migraine Treatment Market Size by Type
Table 2019-2029 China Cgrp-Directed Migraine Treatment Market Size
Table 2019-2029 India Cgrp-Directed Migraine Treatment Market Size
Table 2019-2029 Japan Cgrp-Directed Migraine Treatment Market Size
Table 2019-2029 South Korea Cgrp-Directed Migraine Treatment Market Size
Table 2019-2029 Southeast Asia Cgrp-Directed Migraine Treatment Market Size
Table 2019-2029 Australia Cgrp-Directed Migraine Treatment Market Size
Table 2019-2029 Europe Cgrp-Directed Migraine Treatment Market Size
Figure 2019-2029 Europe Cgrp-Directed Migraine Treatment Market Size and CAGR
Table 2019-2029 Europe Cgrp-Directed Migraine Treatment Market Size by Application
Table 2019-2024 Europe Cgrp-Directed Migraine Treatment Key Players Revenue
Table 2019-2024 Europe Cgrp-Directed Migraine Treatment Key Players Market Share
Table 2019-2029 Europe Cgrp-Directed Migraine Treatment Market Size by Type
Table 2019-2029 Germany Cgrp-Directed Migraine Treatment Market Size
Table 2019-2029 France Cgrp-Directed Migraine Treatment Market Size
Table 2019-2029 United Kingdom Cgrp-Directed Migraine Treatment Market Size
Table 2019-2029 Italy Cgrp-Directed Migraine Treatment Market Size
Table 2019-2029 Spain Cgrp-Directed Migraine Treatment Market Size
Table 2019-2029 Belgium Cgrp-Directed Migraine Treatment Market Size
Table 2019-2029 Netherlands Cgrp-Directed Migraine Treatment Market Size
Table 2019-2029 Austria Cgrp-Directed Migraine Treatment Market Size
Table 2019-2029 Poland Cgrp-Directed Migraine Treatment Market Size
Table 2019-2029 Russia Cgrp-Directed Migraine Treatment Market Size
Table 2019-2029 MEA Cgrp-Directed Migraine Treatment Market Size
Figure 2019-2029 MEA Cgrp-Directed Migraine Treatment Market Size and CAGR
Table 2019-2029 MEA Cgrp-Directed Migraine Treatment Market Size by Application
Table 2019-2024 MEA Cgrp-Directed Migraine Treatment Key Players Revenue
Table 2019-2024 MEA Cgrp-Directed Migraine Treatment Key Players Market Share
Table 2019-2029 MEA Cgrp-Directed Migraine Treatment Market Size by Type
Table 2019-2029 Egypt Cgrp-Directed Migraine Treatment Market Size
Table 2019-2029 Israel Cgrp-Directed Migraine Treatment Market Size
Table 2019-2029 South Africa Cgrp-Directed Migraine Treatment Market Size
Table 2019-2029 Gulf Cooperation Council Countries Cgrp-Directed Migraine Treatment Market Size
Table 2019-2029 Turkey Cgrp-Directed Migraine Treatment Market Size
Table 2019-2024 Global Cgrp-Directed Migraine Treatment Market Size by Region
Table 2019-2024 Global Cgrp-Directed Migraine Treatment Market Size Share by Region
Table 2019-2024 Global Cgrp-Directed Migraine Treatment Market Size by Application
Table 2019-2024 Global Cgrp-Directed Migraine Treatment Market Share by Application
Table 2019-2024 Global Cgrp-Directed Migraine Treatment Key Vendors Revenue
Figure 2019-2024 Global Cgrp-Directed Migraine Treatment Market Size and Growth Rate
Table 2019-2024 Global Cgrp-Directed Migraine Treatment Key Vendors Market Share
Table 2019-2024 Global Cgrp-Directed Migraine Treatment Market Size by Type
Table 2019-2024 Global Cgrp-Directed Migraine Treatment Market Share by Type
Table 2024-2029 Global Cgrp-Directed Migraine Treatment Market Size by Region
Table 2024-2029 Global Cgrp-Directed Migraine Treatment Market Size Share by Region
Table 2024-2029 Global Cgrp-Directed Migraine Treatment Market Size by Application
Table 2024-2029 Global Cgrp-Directed Migraine Treatment Market Share by Application
Table 2024-2029 Global Cgrp-Directed Migraine Treatment Key Vendors Revenue
Figure 2024-2029 Global Cgrp-Directed Migraine Treatment Market Size and Growth Rate
Table 2024-2029 Global Cgrp-Directed Migraine Treatment Key Vendors Market Share
Table 2024-2029 Global Cgrp-Directed Migraine Treatment Market Size by Type
Table 2024-2029 Cgrp-Directed Migraine Treatment Global Market Share by Type

Companies Mentioned

  • Eli Lilly
  • Amgen/Novartis
  • Teva
  • Lundbeck
  • Allergan
  • Biohaven

Related Topics

Related Reports

Calcitonin Gene-Related Peptide (CGRP) Inhibitors Market Report 2025 - Product Image

Calcitonin Gene-Related Peptide (CGRP) Inhibitors Market Report 2025

  • Report
  • 250 Pages
  • Global
From
CGRP Inhibitor Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

CGRP Inhibitor Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Migraine Drugs Market Report by Treatment Type, Drug Type, Route of Administration, Distribution Channel, and Region 2025-2033 - Product Image

Migraine Drugs Market Report by Treatment Type, Drug Type, Route of Administration, Distribution Channel, and Region 2025-2033

  • Report
  • 123 Pages
  • Global
From
CGRP Inhibitors Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2025-2032 - (By Drug Type, Treatment Type, Route of Administration, Distribution Channel, Patient Demographics, Geographic Coverage and By Company) - Product Image

CGRP Inhibitors Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2025-2032 - (By Drug Type, Treatment Type, Route of Administration, Distribution Channel, Patient Demographics, Geographic Coverage and By Company)

  • Report
  • 192 Pages
  • Global
From
Migraine Drug Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Migraine Drug Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 95 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.